HeartFlow is a company that revolutionizes precision heart care by bringing together human ingenuity and advanced technology to help combat heart disease.

HeartFlow

HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. 

Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow’s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. 

We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care. 

For more information, visit www.heartflow.com.


Emergent Medical Partners

HealthCor Partners

U.S. Venture Partners

Lifeforce Capital

Capricorn Investment Group

Panorama Point Partners

Baillie Gifford

Wellington Management

Martis Capital

Rancilio Cube

Bain Capital Life Sciences

Hayfin Capital Management

Janus Henderson Investors

HeartFlow, Inc

We're honored to start the month of July off with Poudre Valley Hospital. We recently celebrated their accomplishment of being selected as a Q1 2024 recipient for #HeartFlow's CT Quality Award. Congratulations on your efforts in coronary CT imaging - well done UC Health! 

#FFRCT #CCTA #AI #heartcare #CAD

When asked how to use the plaque analysis report with patients, Dr. Pursnani replied, “Patients really can relate to seeing the plaque...and are more apt to adopt and take the medical therapy that’s prescribed.” https://bit.ly/3TikVAN 

#HeartFlow #HeartFlowPlaqueAnalysis #Plaque

Please join us in congratulating the Ascension St. Vincent team on being awarded a CT Quality Award for Q1 2024. We're honored to be partnered with a team that is steadily dedicated to proviiding quality cardiovascular care to their patients. Amazing job! 

#CCTA #FFRCT #AI #heartcare #yesCCT

Today we are celebrating the CT imaging team over at Northwell Peconic Bay Medical Center. They've been selected as a recipient of #HeartFlow's CT Quality Award for both Q4 2023 and Q1 2024. What an achievement! Your commitment to quality is truly impressive and we look forward to revolutionizing precision heart care with you all. 

#FFRCT #CCTA #AI #heartcare #yesCCT

St. Michael's Medical Center has earned their very first CT Quality Award for Q1 2024! This CT imaging team's hardwork and dedication to their patients is truly showcased in this award. Congratulations on your first award and we look forward to celebrating many more with you all. 

Virginia Mason Franciscan Health #FFRCT #CCTA #AI #heartcare

10 years into the use of #FractionalFlowReserve #FFR derived from #CTCA, 3 early adopters review illustrative cases and share important lessons learned about #LesionSpecificPhysiology. Colin Barker Mark Rabbat MD,FSCCT,FACC,FAHA Jonathon Leipsic

COM:HEARTFLOW

HeartFlow

Analysis Not Available